transforms diagnostics by leveraging millions of years of evolutionary development in the immune system, tapping into the power of nature itself.
Seroxo
Seroxo is a world-leading IVD company pioneering the development and commercialisation of a transformative technology. The LIT™, a 10-minute finger-prick blood test, is a patented breakthrough technology that assesses real-time, 3D neutrophil function with applications in cancer, sepsis and emergency triage.
Platform
Unleash it with our app and algorithm platform to make disease diagnosis and monitoring simple.
Applications
LIT™ has been clinically demonstrated in cancer, sepsis and infectious disease.
Resources
The resource hub to learn more about LIT™ and the latest publications and news from Seroxo.
Our Global Partners
